Vaxxas Pty Ltd
Brisbane, Queensland, AustraliaPurpose
to develop a measles and rubella microneedle array patch for clinical proof-of-concept.
Grantee
Division
Global Health
Date
OCTOBER 2023
Region served
GLOBAL
Committed amount
$3,897,240
Grant topic
Vaccine Development
Duration (months)
51
Grantee location
Brisbane, Queensland, Australia
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.